Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-04-022148
Filing Date
2004-04-27
Accepted
2004-04-27 16:58:07
Documents
1
Period of Report
2004-04-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 13702
  Complete submission text file 0001209191-04-022148.txt   15575
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address OSI PHARMACEUTICALS INC 58 S. SERVICE RD. MELVILLE NY 11747
VAN NOSTRAND ROBERT L (Reporting) CIK: 0001225198 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15190 | Film No.: 04757582